北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity
作者: Yang, Wenying2; Zhao, Wenhui2,3,4; Xiao, Jianzhong2; Li, Rui5; Zhang, Ping5; Kissimova-Skarbek, Katarzyna1,6; Schneider, Erin1,7; Jia, Weiping8; Ji, Linong9; Guo, Xiaohui10; Shan, Zhongyan11; Liu, Jie12; Tian, Haoming13; Chen, Li14; Zhou, Zhiguang15; Ji, Qiuhe16; Ge, Jiapu17; Chen, Gang18; Brown, Jonathan1
刊名: PLOS ONE
发表日期: 2012-09-26
DOI: 10.1371/journal.pone.0039513
卷: 7, 期:9
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Multidisciplinary Sciences
研究领域[WOS]: Science & Technology - Other Topics
关键词[WOS]: MIDDLE-INCOME COUNTRIES ; CARDIOVASCULAR-DISEASE ; COST-EFFECTIVENESS ; BLOOD-PRESSURE ; FOLLOW-UP ; PREVENTION ; MELLITUS ; BURDEN ; INDIVIDUALS ; PREVALENCE
英文摘要:

Background: The Diabetes Impact Study followed up a large national population-based screening study to estimate the use of and expenditures for medical care caused by diabetes in China and to ascertain the use and cost of essential basic medicines and care.

Methods: In 2009-10, the study team interviewed 1482 adults with diabetes and 1553 adults with glucose tolerance in the normal range from population-based random samples at 12 sites in China. The response rate was 67%.

Findings: After adjusting for age, sex, and urban/rural location, people with diabetes received 1.93 times more days of inpatient treatment, 2.40 times more outpatient visits, and 3.35 times more medications than people with normal glucose tolerance (all p<0.05). Adjusted expenditures for medical care were 3.38 times higher among people with diabetes than among people with normal glucose tolerance (p<0.01, unadjusted 3.97). Persons who were diagnosed with >= 10 years prior to the survey paid 3.75 times as much for medical care as those with <= 5 years of diagnosed diabetes. Among persons with diabetes, 45.2% took medication to control blood sugar, 21.1% took an antihypertensive medicine, 22.4% took daily aspirin, and 1.8% took a statin. Over the three months before the interview, 46.1% of persons with diabetes recalled seeing a doctor, 48.9% recalled a blood pressure measurement, and 54.5% recalled a blood sugar test. Over the year preceding the interview, 32.1% recalled a retinal screening and 17.9% recalled a foot examination.

Conclusions: In China, health care use and costs were dramatically higher for people with diabetes than for people with normal glucose tolerance and, in relative terms, much higher than in industrialized countries. Low-cost generic medicines that would reduce diabetes expenditures were not fully used.

语种: 英语
项目资助者: Economic Study Fund of the International Diabetes Federation (IDF) ; Chinese Diabetes Society ; Merck and Co. ; Novo Nordisk ; Eli Lilly and Co. ; Takeda Pharmaceuticals North America ; GSK, Inc. ; GSK ; Eli Lilly ; Merck ; Roche and Co.
WOS记录号: WOS:000309517300002
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/59402
Appears in Collections:北京大学第二临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Jagiellonian Univ, Coll Med, Inst Publ Hlth, Krakow, Poland
2.Natl Bur Asian Res, Seattle, WA USA
3.Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
4.Peking Univ, Hosp 1, Beijing 100871, Peoples R China
5.Shanxi Prov Peoples Hosp, Taiyuan, Shaanxi, Peoples R China
6.Int Diabet Federat, Brussels, Belgium
7.Ctr Dis Control & Prevent, Atlanta, GA USA
8.Chinese Japanese Friendship Hosp, Beijing, Peoples R China
9.Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China
10.Chinese Acad Med Sci, Beijing 100730, Peoples R China
11.Xiangya Second Hosp, Changsha, Hunan, Peoples R China
12.Xinjiang Uygur Autonomous Reg Hosp, Urumqi, Xinjiang, Peoples R China
13.Fujian Prov Hosp, Fuzhou, Fujiang, Peoples R China
14.Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China
15.Chinese Med Univ, Affiliated Hosp 1, Shenyang, Liaoling, Peoples R China
16.Sichuan Univ, W China Hosp, Chengdu 610064, Sichuan, Peoples R China
17.Shandong Univ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China
18.Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China

Recommended Citation:
Yang, Wenying,Zhao, Wenhui,Xiao, Jianzhong,et al. Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity[J]. PLOS ONE,2012,7(9).
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Yang, Wenying]'s Articles
[Zhao, Wenhui]'s Articles
[Xiao, Jianzhong]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Yang, Wenying]‘s Articles
[Zhao, Wenhui]‘s Articles
[Xiao, Jianzhong]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace